We showed that by treating U87 and U251 GBM cells with two specific JAK3 inhibitors, WHI-P131 and PF-956980, JAK3 activity could be significantly downregulated, and this has tremendous beneficial effects in preventing tumor cell proliferation and inducing cellular differentiation (Supplementary Figure S4). The gene discussed is JAK3; the disease is neoplasm.